These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21502245)

  • 21. The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report.
    Richards JR; Elston TH; Ford RB; Gaskell RM; Hartmann K; Hurley KF; Lappin MR; Levy JK; Rodan I; Scherk M; Schultz RD; Sparkes AH
    J Am Vet Med Assoc; 2006 Nov; 229(9):1405-41. PubMed ID: 17078805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding vaccine safety. Immunization remains our best defense against deadly diseases.
    Meadows M
    FDA Consum; 2001; 35(4):18-23. PubMed ID: 11692879
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of hepatitis A infection in the U.S.
    Le C
    West J Med; 1999 Jun; 170(6):324. PubMed ID: 10443156
    [No Abstract]   [Full Text] [Related]  

  • 24. Allergic reactions to vaccines.
    Alves RR; Gaspar A; Ferreira MB
    Eur Ann Allergy Clin Immunol; 2007 Oct; 39(8):269-77. PubMed ID: 18237005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Vaccine Safety Datalink: a model for monitoring immunization safety.
    Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
    Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintaining the vaccine safety net.
    Hannan C; Buchanan AD; Monroe J
    Pediatrics; 2009 Dec; 124 Suppl 5():S571-2. PubMed ID: 19948593
    [No Abstract]   [Full Text] [Related]  

  • 27. Postlicensure epidemiology of childhood vaccination: the Danish experience.
    Hviid A
    Expert Rev Vaccines; 2006 Oct; 5(5):641-9. PubMed ID: 17181438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommended childhood immunization schedule--United States, January-June 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jan; 44(51-52):940-3. PubMed ID: 8531913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine preventable diseases in the United States, 1996.
    Commun Dis Rep CDR Wkly; 1997 Sep; 7(39):347, 350. PubMed ID: 9345809
    [No Abstract]   [Full Text] [Related]  

  • 30. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007.
    Hua W; Izurieta HS; Slade B; Belay ED; Haber P; Tiernan R; Woo EJ; Iskander J; Braun MM; Ball R
    Pediatr Infect Dis J; 2009 Nov; 28(11):943-7. PubMed ID: 19755926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Child vaccination, part 1: routine vaccines.
    Zimmerman RK; Burns IT
    J Fam Pract; 2000 Sep; 49(9 Suppl):S22-33. PubMed ID: 11032190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.
    Yih WK; Kulldorff M; Fireman BH; Shui IM; Lewis EM; Klein NP; Baggs J; Weintraub ES; Belongia EA; Naleway A; Gee J; Platt R; Lieu TA
    Pediatrics; 2011 May; 127 Suppl 1():S54-64. PubMed ID: 21502252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine finance resources for physicians.
    Sobczyk E
    Pediatrics; 2009 Dec; 124 Suppl 5():S573-6. PubMed ID: 19948594
    [No Abstract]   [Full Text] [Related]  

  • 38. Tracking vaccine-safety inquiries to detect signals and monitor public concerns.
    Miller E; Batten B; Hampton L; Campbell SR; Gao J; Iskander J
    Pediatrics; 2011 May; 127 Suppl 1():S87-91. PubMed ID: 21502241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General recommendations on immunization. Recommendation of the Immunization Practices Advisory Committee.
    Ann Intern Med; 1983 May; 98(5 Pt 1):615-22. PubMed ID: 6846976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.